These medications can help reduce hunger, increase fullness, and make it easier for appropriate patients to follow a sustainable medical weight loss plan
Are there alternatives within the GLP-1 class that might also be suitable
[15] [16] Early-phase clinical trials are investigating semaglutide's potential role in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, though no cognitive benefits have been established in humans at this stage
Endocrine Reviews
If you do not achieve adequate weight loss on semaglutide, your provider may recommend increasing the dose (if not already at maximum), switching to tirzepatide (which works through a dual mechanism), or adding complementary approaches such as hormone optimization or more intensive nutritional support
If you are new to GLP-1 medications, or if you have not taken one in some time, you will begin at Tier 1